172 related articles for article (PubMed ID: 37379307)
1. Gene and pathway based burden analyses in familial lymphoid cancer cases: Rare variants in immune pathway genes.
Ralli S; Jones SJ; Leach S; Lynch HT; Brooks-Wilson AR
PLoS One; 2023; 18(6):e0287602. PubMed ID: 37379307
[TBL] [Abstract][Full Text] [Related]
2. Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families.
Shahi RB; De Brakeleer S; Caljon B; Pauwels I; Bonduelle M; Joris S; Fontaine C; Vanhoeij M; Van Dooren S; Teugels E; De Grève J
BMC Cancer; 2019 Apr; 19(1):313. PubMed ID: 30947698
[TBL] [Abstract][Full Text] [Related]
3. Sequencing at lymphoid neoplasm susceptibility loci maps six myeloma risk genes.
Waller RG; Klein RJ; Vijai J; McKay JD; Clay-Gilmour A; Wei X; Madsen MJ; Sborov DW; Curtin K; Slager SL; Offit K; Vachon CM; Lipkin SM; Dumontet C; Camp NJ
Hum Mol Genet; 2021 Jun; 30(12):1142-1153. PubMed ID: 33751038
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the contribution of germline variants in BRCA1 and BRCA2 to uveal and cutaneous melanoma.
Johansson PA; Nathan V; Bourke LM; Palmer JM; Zhang T; Symmons J; Howlie M; Patch AM; Read J; Holland EA; Schmid H; Warrier S; Glasson W; Höiom V; Wadt K; Jönsson G; Olsson H; Ingvar C; Mann G; Brown KM; Hayward NK; Pritchard AL
Melanoma Res; 2019 Oct; 29(5):483-490. PubMed ID: 31464824
[TBL] [Abstract][Full Text] [Related]
5. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma.
Mirabello L; Zhu B; Koster R; Karlins E; Dean M; Yeager M; Gianferante M; Spector LG; Morton LM; Karyadi D; Robison LL; Armstrong GT; Bhatia S; Song L; Pankratz N; Pinheiro M; Gastier-Foster JM; Gorlick R; de Toledo SRC; Petrilli AS; Patino-Garcia A; Lecanda F; Gutierrez-Jimeno M; Serra M; Hattinger C; Picci P; Scotlandi K; Flanagan AM; Tirabosco R; Amary MF; Kurucu N; Ilhan IE; Ballinger ML; Thomas DM; Barkauskas DA; Mejia-Baltodano G; Valverde P; Hicks BD; Zhu B; Wang M; Hutchinson AA; Tucker M; Sampson J; Landi MT; Freedman ND; Gapstur S; Carter B; Hoover RN; Chanock SJ; Savage SA
JAMA Oncol; 2020 May; 6(5):724-734. PubMed ID: 32191290
[TBL] [Abstract][Full Text] [Related]
6. Identification of Rare Variants Predisposing to Thyroid Cancer.
Wang Y; Liyanarachchi S; Miller KE; Nieminen TT; Comiskey DF; Li W; Brock P; Symer DE; Akagi K; DeLap KE; He H; Koboldt DC; de la Chapelle A
Thyroid; 2019 Jul; 29(7):946-955. PubMed ID: 30957677
[No Abstract] [Full Text] [Related]
7. Exome-Wide Pan-Cancer Analysis of Germline Variants in 8,719 Individuals Finds Little Evidence of Rare Variant Associations.
Guan Z; Shen R; Begg CB
Hum Hered; 2021; 86(1-4):34-44. PubMed ID: 34718237
[TBL] [Abstract][Full Text] [Related]
8. Candidate colorectal cancer predisposing gene variants in Chinese early-onset and familial cases.
Zhang JX; Fu L; de Voer RM; Hahn MM; Jin P; Lv CX; Verwiel ET; Ligtenberg MJ; Hoogerbrugge N; Kuiper RP; Sheng JQ; Geurts van Kessel A
World J Gastroenterol; 2015 Apr; 21(14):4136-49. PubMed ID: 25892863
[TBL] [Abstract][Full Text] [Related]
9. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
[TBL] [Abstract][Full Text] [Related]
10. Whole Exome Sequencing Identifies Novel De Novo Variants Interacting with Six Gene Networks in Autism Spectrum Disorder.
Kim N; Kim KH; Lim WJ; Kim J; Kim SA; Yoo HJ
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374967
[TBL] [Abstract][Full Text] [Related]
11. Genetic Analysis of Functional Rare Germline Variants across Nine Cancer Types from an Electronic Health Record Linked Biobank.
Shivakumar M; Miller JE; Dasari VR; Zhang Y; Lee MTM; Carey DJ; Gogoi R; Kim D;
Cancer Epidemiol Biomarkers Prev; 2021 Sep; 30(9):1681-1688. PubMed ID: 34244158
[TBL] [Abstract][Full Text] [Related]
12. Whole genome sequencing identifies rare germline variants enriched in cancer related genes in first degree relatives of familial pancreatic cancer patients.
Tan M; Brusgaard K; Gerdes AM; Mortensen MB; Detlefsen S; Schaffalitzky de Muckadell OB; Joergensen MT
Clin Genet; 2021 Nov; 100(5):551-562. PubMed ID: 34313325
[TBL] [Abstract][Full Text] [Related]
13. Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer.
Esteban-Jurado C; Vila-Casadesús M; Garre P; Lozano JJ; Pristoupilova A; Beltran S; Muñoz J; Ocaña T; Balaguer F; López-Cerón M; Cuatrecasas M; Franch-Expósito S; Piqué JM; Castells A; Carracedo A; Ruiz-Ponte C; Abulí A; Bessa X; Andreu M; Bujanda L; Caldés T; Castellví-Bel S
Genet Med; 2015 Feb; 17(2):131-42. PubMed ID: 25058500
[TBL] [Abstract][Full Text] [Related]
14. Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families.
Van Marcke C; Helaers R; De Leener A; Merhi A; Schoonjans CA; Ambroise J; Galant C; Delrée P; Rothé F; Bar I; Khoury E; Brouillard P; Canon JL; Vuylsteke P; Machiels JP; Berlière M; Limaye N; Vikkula M; Duhoux FP
Breast Cancer Res; 2020 Apr; 22(1):36. PubMed ID: 32295625
[TBL] [Abstract][Full Text] [Related]
15. Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility.
Lee NY; Hum M; Amali AA; Lim WK; Wong M; Myint MK; Tay RJ; Ong PY; Samol J; Lim CW; Ang P; Tan MH; Lee SC; Lee ASG
Hum Genomics; 2022 Nov; 16(1):61. PubMed ID: 36424660
[TBL] [Abstract][Full Text] [Related]
16. Focused Analysis of Exome Sequencing Data for Rare Germline Mutations in Familial and Sporadic Lung Cancer.
Liu Y; Kheradmand F; Davis CF; Scheurer ME; Wheeler D; Tsavachidis S; Armstrong G; Simpson C; Mandal D; Kupert E; Anderson M; You M; Xiong D; Pikielny C; Schwartz AG; Bailey-Wilson J; Gaba C; De Andrade M; Yang P; Pinney SM; ; Amos CI; Spitz MR
J Thorac Oncol; 2016 Jan; 11(1):52-61. PubMed ID: 26762739
[TBL] [Abstract][Full Text] [Related]
17. Association Between Germline Mutations in BRF1, a Subunit of the RNA Polymerase III Transcription Complex, and Hereditary Colorectal Cancer.
Bellido F; Sowada N; Mur P; Lázaro C; Pons T; Valdés-Mas R; Pineda M; Aiza G; Iglesias S; Soto JL; Urioste M; Caldés T; Balbín M; Blay P; Rueda D; Durán M; Valencia A; Moreno V; Brunet J; Blanco I; Navarro M; Calin GA; Borck G; Puente XS; Capellá G; Valle L
Gastroenterology; 2018 Jan; 154(1):181-194.e20. PubMed ID: 28912018
[TBL] [Abstract][Full Text] [Related]
18. Whole Exome Sequencing Identifies
Skopelitou D; Miao B; Srivastava A; Kumar A; Kuswick M; Dymerska D; Paramasivam N; Schlesner M; Lubinski J; Hemminki K; Försti A; Bandapalli OR
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33673279
[TBL] [Abstract][Full Text] [Related]
19. Exome Sequencing of Familial Bipolar Disorder.
Goes FS; Pirooznia M; Parla JS; Kramer M; Ghiban E; Mavruk S; Chen YC; Monson ET; Willour VL; Karchin R; Flickinger M; Locke AE; Levy SE; Scott LJ; Boehnke M; Stahl E; Moran JL; Hultman CM; Landén M; Purcell SM; Sklar P; Zandi PP; McCombie WR; Potash JB
JAMA Psychiatry; 2016 Jun; 73(6):590-7. PubMed ID: 27120077
[TBL] [Abstract][Full Text] [Related]
20. Using linkage studies combined with whole-exome sequencing to identify novel candidate genes for familial colorectal cancer.
Toma C; Díaz-Gay M; Franch-Expósito S; Arnau-Collell C; Overs B; Muñoz J; Bonjoch L; Soares de Lima Y; Ocaña T; Cuatrecasas M; Castells A; Bujanda L; Balaguer F; Cubiella J; Caldés T; Fullerton JM; Castellví-Bel S
Int J Cancer; 2020 Mar; 146(6):1568-1577. PubMed ID: 31525256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
